gentamicin has been researched along with Infective Endocarditis in 80 studies
Gentamicins: A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Current guidelines recommend either ampicillin plus ceftriaxone (AC) or amoxicillin/ampicillin plus gentamicin (AG) with an equivalent class IB recommendation in Enterococcus faecalis endocarditis." | 9.22 | Time to abandon ampicillin plus gentamicin in favour of ampicillin plus ceftriaxone in Enterococcus faecalis infective endocarditis? A meta-analysis of comparative trials. ( Hoppe, UC; Lichtenauer, M; Mirna, M; Schmutzler, L; Topf, A, 2022) |
| "The aim of this randomized study was to investigate the effects of once versus twice daily gentamicin dosing on renal function and measures of infectious disease in a population with infective endocarditis (IE)." | 9.15 | Once versus twice daily gentamicin dosing for infective endocarditis: a randomized clinical trial. ( Bruun, NE; Buchholtz, K; Hassager, C; Larsen, CT; Schaadt, B, 2011) |
| "International guidelines recommend high-dose cloxacillin for endocarditis or osteoarticular infections due to methicillin-susceptible staphylococci." | 8.98 | Acute kidney injury during treatment with high-dose cloxacillin: a report of 23 cases and literature review. ( Golbin, L; Lavergne, A; Polard, E; Rioux-Leclercq, N; Tattevin, P; Triquet, L; Vigneau, C, 2018) |
| "The American Heart Association endorses penicillin G or ampicillin with gentamicin (A+G) or dual beta-lactam therapy with ampicillin and ceftriaxone (A+C) as first-line regimens for Enterococcus faecalis infective endocarditis (EFIE) caused by penicillin-susceptible isolates." | 8.12 | Evaluation of penicillin-gentamicin and dual beta-lactam therapies in Enterococcus faecalis infective endocarditis. ( Everson, N; Freeman, L; McDaniel, L; Milkovits, A, 2022) |
| "A retrospective observational case series from multiple hospitals of patients aged 15 years or over with enterococcal endocarditis diagnosed between July 2013 and June 2019 who received at least 14 days of outpatient continuous-infusion benzylpenicillin combined with either gentamicin or ceftriaxone for synergy." | 8.02 | Outpatient continuous-infusion benzylpenicillin combined with either gentamicin or ceftriaxone for enterococcal endocarditis. ( Bhally, H; Briggs, S; Broom, M; Duffy, E; Everts, G; Everts, R; Lowe, B; McBride, S, 2021) |
| "In vitro and in vivo activity of daptomycin alone or plus either cloxacillin or fosfomycin compared with cloxacillin alone and cloxacillin plus gentamicin were evaluated in a rabbit model of MSSA experimental endocarditis (EE)." | 7.96 | Cloxacillin or fosfomycin plus daptomycin combinations are more active than cloxacillin monotherapy or combined with gentamicin against MSSA in a rabbit model of experimental endocarditis. ( Almela, M; Ambrosioni, J; Cañas, MA; Castañeda, X; Falces, C; Fuster, D; García-de-la-Mària, C; García-González, J; Gasch, O; Hernández-Meneses, M; Llopis, J; Marco, F; Miró, JM; Moreno, A; Pericàs, JM; Quintana, E; Sandoval, E; Soy, D; Téllez, A; Tolosana, JM; Vidal, B, 2020) |
| "The aim of this study was to assess changes in antibiotic resistance, epidemiology and outcome among patients with Enterococcus faecalis infective endocarditis (EFIE) and to compare the efficacy and safety of the combination of ampicillin and gentamicin (A+G) with that of ampicillin plus ceftriaxone (A+C)." | 7.80 | Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone. ( Almela, M; Armero, Y; Castañeda, X; Cervera, C; del Rio, A; Falces, C; Garcia de la Maria, C; Gatell, JM; Marco, F; Mestres, CA; Miro, JM; Moreno, A; Ninot, S; Pericas, JM; Soy, D, 2014) |
| "The aim of this study was to compare the effectiveness of the ampicillin plus ceftriaxone (AC) and ampicillin plus gentamicin (AG) combinations for treating Enterococcus faecalis infective endocarditis (EFIE)." | 7.79 | Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating enterococcus faecalis infective endocarditis. ( Almirante, B; de Alarcón, A; de la Torre, J; Falcone, M; Fernández-Hidalgo, N; Gálvez, J; Gavaldà, J; Gurgui, M; Hidalgo-Tenorio, C; Lomas, JM; López, J; López-Medrano, F; Martínez-Lacasa, X; Montejo, M; Pahissa, A; Peña, C; Plata, A; Ruiz, J; Sáez, C; Vallejo, N; Vilacosta, I, 2013) |
| " This study investigated the epidemiological, microbiological, and prognostic characteristics of high-level gentamicin-resistant (HLGR) enterococcal bacteremia, including severe cases of infective endocarditis, in Japan." | 7.78 | A surveillance of high-level gentamicin-resistant enterococcal bacteremia. ( Araoka, H; Kimura, M; Yoneyama, A, 2012) |
| "US and European guidelines recommend a daily divided gentamicin dose (3 mg/kg in two or three equally divided doses) for the treatment of infective endocarditis caused by staphylococci or enterococci, but once-daily dosing (3 mg/kg/day) is recommended for streptococcal endocarditis." | 7.78 | A survey on the use of gentamicin in infective endocarditis. ( Alfandari, S; Béraud, G; Couet, W; Elsendoorn, A; Godet, C; Le Moal, G; Roblot, F; Roblot, P; Tattevin, P, 2012) |
| "A major and significant weight gain can occur after a six-week intravenous treatment by vancomycin plus gentamycin for IE with a risk of obesity, especially in males older than 65 who have not undergone surgery." | 7.76 | Vancomycin treatment of infective endocarditis is linked with recently acquired obesity. ( Angelakis, E; Casalta, JP; Habib, G; Raoult, D; Richet, H; Thuny, F, 2010) |
| "Gentamicin is often used to treat infective endocarditis (IE)." | 7.75 | Severity of gentamicin's nephrotoxic effect on patients with infective endocarditis: a prospective observational cohort study of 373 patients. ( Bruun, NE; Buchholtz, K; Hassager, C; Larsen, CT, 2009) |
| "The effect of production of the aminoglycoside 6'-N-acetyltransferase [AAC(6')-IB] in Klebsiella pneumoniae on the outcome of amikacin and isepamicin treatment of rabbits with experimental endocarditis was assessed." | 7.69 | Resistance to amikacin and isepamicin in rabbits with experimental endocarditis of an aac(6')-Ib-bearing strain of Klebsiella pneumoniae susceptible in vitro. ( Carbon, C; Caulin, E; Collatz, E; Coutrot, A, 1996) |
| "The pharmacokinetics and efficacy of isepamicin were compared with those of amikacin and gentamicin in a rabbit model of endocarditis due to Klebsiella pneumoniae CF104 producing beta-lactamase TEM-3 and aminoglycoside acetyltransferase AAC(6')-IV." | 7.69 | Activity of isepamicin and selection of permeability mutants to beta-lactams during aminoglycoside therapy of experimental endocarditis due to Klebsiella pneumoniae CF104 producing an aminoglycoside acetyltransferase 6' modifying enzyme and a TEM-3 beta-l ( Carbon, C; Farinotti, R; Goldstein, F; Gutmann, L; Mainardi, JL; Mohler, J; Zhou, XY, 1994) |
| "The influence of the gentamicin dosing regimen was studied in experimental Enterococcus faecalis endocarditis." | 7.69 | Influence of gentamicin dosing interval on the efficacy of penicillin-containing regimens in experimental Enterococcus faecalis endocarditis. ( Marangos, MN; Nicolau, DP; Nightingale, CH; Quintiliani, R, 1997) |
| "Antibiotic therapy of methicillin-resistant Staphylococcus epidermidis endocarditis was investigated with the rabbit endocarditis model." | 7.66 | Therapy of methicillin-resistant Staphylococcus epidermidis experimental endocarditis. ( Lowy, FD; Steigbigel, NH; Wexler, MA, 1982) |
| "Gentamicin shows large variations in half-life and volume of distribution (Vd) within and between individuals." | 5.46 | Pharmacokinetic modeling of gentamicin in treatment of infective endocarditis: Model development and validation of existing models. ( Gomes, A; Proost, JH; Sinha, B; Touw, DJ; van der Wijk, L, 2017) |
| " The purpose of the present study was to quantify the biofilm formation of methicillin (meticillin)-resistant Staphylococcus aureus (MRSA) isolates obtained from patients with IE and to evaluate the in vitro activities of daptomycin and vancomycin alone and in combination with rifampin (rifampicin) or gentamicin while monitoring the isolates for the development of resistance." | 5.35 | Activities of daptomycin and vancomycin alone and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditis. ( LaPlante, KL; Woodmansee, S, 2009) |
| "Current guidelines recommend either ampicillin plus ceftriaxone (AC) or amoxicillin/ampicillin plus gentamicin (AG) with an equivalent class IB recommendation in Enterococcus faecalis endocarditis." | 5.22 | Time to abandon ampicillin plus gentamicin in favour of ampicillin plus ceftriaxone in Enterococcus faecalis infective endocarditis? A meta-analysis of comparative trials. ( Hoppe, UC; Lichtenauer, M; Mirna, M; Schmutzler, L; Topf, A, 2022) |
| "International guidelines recommend high-dose cloxacillin for endocarditis or osteoarticular infections due to methicillin-susceptible staphylococci." | 4.98 | Acute kidney injury during treatment with high-dose cloxacillin: a report of 23 cases and literature review. ( Golbin, L; Lavergne, A; Polard, E; Rioux-Leclercq, N; Tattevin, P; Triquet, L; Vigneau, C, 2018) |
| "The American Heart Association endorses penicillin G or ampicillin with gentamicin (A+G) or dual beta-lactam therapy with ampicillin and ceftriaxone (A+C) as first-line regimens for Enterococcus faecalis infective endocarditis (EFIE) caused by penicillin-susceptible isolates." | 4.12 | Evaluation of penicillin-gentamicin and dual beta-lactam therapies in Enterococcus faecalis infective endocarditis. ( Everson, N; Freeman, L; McDaniel, L; Milkovits, A, 2022) |
| " The diagnosis was based on the presence of vegetations on the bioprosthesis seen on the echocardiogram, positive blood cultures and fever, and a favorable clinical outcome following the treatment with ceftriaxone and gentamicin." | 4.02 | Aerococcus spp infective endocarditis following a prostate biopsy: a case report. ( Barbosa, DACK; Barros, MDNDDS; Carvalho, MH; Rodrigues, JV; Santos-Veloso, MAO, 2021) |
| "A retrospective observational case series from multiple hospitals of patients aged 15 years or over with enterococcal endocarditis diagnosed between July 2013 and June 2019 who received at least 14 days of outpatient continuous-infusion benzylpenicillin combined with either gentamicin or ceftriaxone for synergy." | 4.02 | Outpatient continuous-infusion benzylpenicillin combined with either gentamicin or ceftriaxone for enterococcal endocarditis. ( Bhally, H; Briggs, S; Broom, M; Duffy, E; Everts, G; Everts, R; Lowe, B; McBride, S, 2021) |
| "In vitro and in vivo activity of daptomycin alone or plus either cloxacillin or fosfomycin compared with cloxacillin alone and cloxacillin plus gentamicin were evaluated in a rabbit model of MSSA experimental endocarditis (EE)." | 3.96 | Cloxacillin or fosfomycin plus daptomycin combinations are more active than cloxacillin monotherapy or combined with gentamicin against MSSA in a rabbit model of experimental endocarditis. ( Almela, M; Ambrosioni, J; Cañas, MA; Castañeda, X; Falces, C; Fuster, D; García-de-la-Mària, C; García-González, J; Gasch, O; Hernández-Meneses, M; Llopis, J; Marco, F; Miró, JM; Moreno, A; Pericàs, JM; Quintana, E; Sandoval, E; Soy, D; Téllez, A; Tolosana, JM; Vidal, B, 2020) |
| "To define the clinical presentation of aerococcal infective endocarditis (IE) and the prevalence of synergy between penicillin and gentamicin on aerococcal isolates." | 3.83 | Clinical and microbiological features of infective endocarditis caused by aerococci. ( Nilson, B; Olaison, L; Rasmussen, M; Sunnerhagen, T, 2016) |
| "The aim of this study was to assess changes in antibiotic resistance, epidemiology and outcome among patients with Enterococcus faecalis infective endocarditis (EFIE) and to compare the efficacy and safety of the combination of ampicillin and gentamicin (A+G) with that of ampicillin plus ceftriaxone (A+C)." | 3.80 | Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone. ( Almela, M; Armero, Y; Castañeda, X; Cervera, C; del Rio, A; Falces, C; Garcia de la Maria, C; Gatell, JM; Marco, F; Mestres, CA; Miro, JM; Moreno, A; Ninot, S; Pericas, JM; Soy, D, 2014) |
| "The aim of this study was to compare the effectiveness of the ampicillin plus ceftriaxone (AC) and ampicillin plus gentamicin (AG) combinations for treating Enterococcus faecalis infective endocarditis (EFIE)." | 3.79 | Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating enterococcus faecalis infective endocarditis. ( Almirante, B; de Alarcón, A; de la Torre, J; Falcone, M; Fernández-Hidalgo, N; Gálvez, J; Gavaldà, J; Gurgui, M; Hidalgo-Tenorio, C; Lomas, JM; López, J; López-Medrano, F; Martínez-Lacasa, X; Montejo, M; Pahissa, A; Peña, C; Plata, A; Ruiz, J; Sáez, C; Vallejo, N; Vilacosta, I, 2013) |
| "US and European guidelines recommend a daily divided gentamicin dose (3 mg/kg in two or three equally divided doses) for the treatment of infective endocarditis caused by staphylococci or enterococci, but once-daily dosing (3 mg/kg/day) is recommended for streptococcal endocarditis." | 3.78 | A survey on the use of gentamicin in infective endocarditis. ( Alfandari, S; Béraud, G; Couet, W; Elsendoorn, A; Godet, C; Le Moal, G; Roblot, F; Roblot, P; Tattevin, P, 2012) |
| " This study investigated the epidemiological, microbiological, and prognostic characteristics of high-level gentamicin-resistant (HLGR) enterococcal bacteremia, including severe cases of infective endocarditis, in Japan." | 3.78 | A surveillance of high-level gentamicin-resistant enterococcal bacteremia. ( Araoka, H; Kimura, M; Yoneyama, A, 2012) |
| "A major and significant weight gain can occur after a six-week intravenous treatment by vancomycin plus gentamycin for IE with a risk of obesity, especially in males older than 65 who have not undergone surgery." | 3.76 | Vancomycin treatment of infective endocarditis is linked with recently acquired obesity. ( Angelakis, E; Casalta, JP; Habib, G; Raoult, D; Richet, H; Thuny, F, 2010) |
| "Gentamicin is often used to treat infective endocarditis (IE)." | 3.75 | Severity of gentamicin's nephrotoxic effect on patients with infective endocarditis: a prospective observational cohort study of 373 patients. ( Bruun, NE; Buchholtz, K; Hassager, C; Larsen, CT, 2009) |
| "Antibiotic treatment with penicillin and gentamicin had a high rate of success in patients with infective endocarditis caused by NVS." | 3.74 | Infective endocarditis caused by nutritionally variant streptococci. ( Hsu, RB; Lin, CH, 2007) |
| "Corynebacterium diphtheriae, generally considered an extracellular coloniser, was evaluated for its ability to enter and survive within HEp-2 monolayers by gentamicin protection assay." | 3.71 | Intracellular viability of toxigenic Corynebacterium diphtheriae strains in HEp-2 cells. ( Andrade, AF; Fonseca, LS; Formiga, LC; Hirata, R; Mattos-Guaraldi, AL; Monteiro-Leal, LH; Nagao, PE; Napoleão, F, 2002) |
| "The effect of production of the aminoglycoside 6'-N-acetyltransferase [AAC(6')-IB] in Klebsiella pneumoniae on the outcome of amikacin and isepamicin treatment of rabbits with experimental endocarditis was assessed." | 3.69 | Resistance to amikacin and isepamicin in rabbits with experimental endocarditis of an aac(6')-Ib-bearing strain of Klebsiella pneumoniae susceptible in vitro. ( Carbon, C; Caulin, E; Collatz, E; Coutrot, A, 1996) |
| "The pharmacokinetics and efficacy of isepamicin were compared with those of amikacin and gentamicin in a rabbit model of endocarditis due to Klebsiella pneumoniae CF104 producing beta-lactamase TEM-3 and aminoglycoside acetyltransferase AAC(6')-IV." | 3.69 | Activity of isepamicin and selection of permeability mutants to beta-lactams during aminoglycoside therapy of experimental endocarditis due to Klebsiella pneumoniae CF104 producing an aminoglycoside acetyltransferase 6' modifying enzyme and a TEM-3 beta-l ( Carbon, C; Farinotti, R; Goldstein, F; Gutmann, L; Mainardi, JL; Mohler, J; Zhou, XY, 1994) |
| "The influence of the gentamicin dosing regimen was studied in experimental Enterococcus faecalis endocarditis." | 3.69 | Influence of gentamicin dosing interval on the efficacy of penicillin-containing regimens in experimental Enterococcus faecalis endocarditis. ( Marangos, MN; Nicolau, DP; Nightingale, CH; Quintiliani, R, 1997) |
| "Antibiotic therapy of methicillin-resistant Staphylococcus epidermidis endocarditis was investigated with the rabbit endocarditis model." | 3.66 | Therapy of methicillin-resistant Staphylococcus epidermidis experimental endocarditis. ( Lowy, FD; Steigbigel, NH; Wexler, MA, 1982) |
| "Infective endocarditis is a serious, life-threatening condition with mortality of 30% at one year." | 2.50 | Infective endocarditis: therapeutic options and indications for surgery. ( Malhotra, A; Prendergast, B; Rayner, J; Williams, TM, 2014) |
| "Metronidazole was introduced (500mg X 3 by day)." | 1.72 | ( Boukobza, M; Duval, X; Laissy, JP; Raffoul, R, 2022) |
| "Infective endocarditis is associated with significant morbidity and mortality, despite advances in diagnosis and treatment strategies." | 1.51 | No Fever, No Murmur, No Problem? A Concealed Case of Infective Endocarditis. ( Gorman, M; McCann, M; McKeown, B, 2019) |
| "Embolic stroke is the most common neurological complication of infective endocarditis and a major source of morbidity and mortality." | 1.40 | Intravenous thrombolysis is unsafe in stroke due to infective endocarditis. ( Anderson, NE; Barber, PA; Brownlee, WJ, 2014) |
| " The purpose of the present study was to quantify the biofilm formation of methicillin (meticillin)-resistant Staphylococcus aureus (MRSA) isolates obtained from patients with IE and to evaluate the in vitro activities of daptomycin and vancomycin alone and in combination with rifampin (rifampicin) or gentamicin while monitoring the isolates for the development of resistance." | 1.35 | Activities of daptomycin and vancomycin alone and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditis. ( LaPlante, KL; Woodmansee, S, 2009) |
| "henselae endocarditis have been reported to date, none with associated mycotic aneurysm but most often located on the bicuspid aortic valve, and usually with severe valvular damage due to late diagnosis." | 1.35 | [Infective endocarditis due to Bartonella henselae following a rupture of a cerebral aneurysm]. ( de La Blanchardière, A; du Cheyron, D; Fournier, PE; Haustraete, E; Lepage, O; Verdon, R, 2009) |
| " However, the dosage and combinations to be used require further study." | 1.29 | Treatment of endocarditis with teicoplanin: a retrospective analysis of 104 cases. ( Gaya, H; Wilson, AP, 1996) |
| "Because of suspicion of thrombotic thrombocytopenic purpura, treatment with fresh plasma by infusion was immediately initiated." | 1.28 | [Embolizing aortic valve endocarditis in the differential diagnosis of thrombotic thrombocytopenic purpura]. ( Aul, C; Heyll, A; Meckenstock, G; Thomas, M; Vogt, M, 1992) |
| "Extraneous infective endocarditis is most often caused by staphylococci, with Gram-negative bacilli and fungi also quite frequent infecting agents." | 1.25 | The choice of antibiotic for treating infective endocarditis. ( Gray, IR, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (12.50) | 18.7374 |
| 1990's | 12 (15.00) | 18.2507 |
| 2000's | 10 (12.50) | 29.6817 |
| 2010's | 37 (46.25) | 24.3611 |
| 2020's | 11 (13.75) | 2.80 |
| Authors | Studies |
|---|---|
| Mirna, M | 1 |
| Topf, A | 1 |
| Schmutzler, L | 1 |
| Hoppe, UC | 1 |
| Lichtenauer, M | 1 |
| Freeman, L | 1 |
| Milkovits, A | 1 |
| McDaniel, L | 1 |
| Everson, N | 1 |
| Ferreira, AI | 1 |
| Oliveira E Silva, F | 1 |
| Reis, J | 1 |
| Henriques, M | 1 |
| Almeida, J | 1 |
| Boukobza, M | 1 |
| Raffoul, R | 1 |
| Duval, X | 1 |
| Laissy, JP | 1 |
| Danneels, P | 1 |
| Hamel, JF | 1 |
| Picard, L | 1 |
| Rezig, S | 1 |
| Martinet, P | 1 |
| Lorleac'h, A | 1 |
| Talarmin, JP | 1 |
| Buzelé, R | 1 |
| Guimard, T | 1 |
| Le Moal, G | 2 |
| Brochard-Libois, J | 1 |
| Beaudron, A | 1 |
| Letheulle, J | 1 |
| Codde, C | 1 |
| Chenouard, R | 1 |
| Boutoille, D | 1 |
| Lemaignen, A | 1 |
| Bernard, L | 1 |
| Cattoir, V | 1 |
| Dubée, V | 1 |
| Luque-Paz, D | 1 |
| Cuervo, G | 1 |
| Miró, JM | 5 |
| Tattevin, P | 3 |
| Kuncová, K | 1 |
| Žemličková, H | 1 |
| Jäger, J | 1 |
| Ryšková, L | 1 |
| Plíšková, L | 1 |
| Bolehovská, R | 1 |
| Pojar, M | 1 |
| Ramos-Martínez, A | 1 |
| Pericàs, JM | 3 |
| Fernández-Cruz, A | 1 |
| Muñoz, P | 1 |
| Valerio, M | 1 |
| Kestler, M | 1 |
| Montejo, M | 2 |
| Fariñas, MC | 1 |
| Sousa, D | 1 |
| Domínguez, F | 1 |
| Ojeda-Burgos, G | 1 |
| Plata, A | 2 |
| Vidal, L | 1 |
| García-de-la-Mària, C | 1 |
| Gasch, O | 1 |
| Castañeda, X | 2 |
| García-González, J | 1 |
| Soy, D | 2 |
| Cañas, MA | 1 |
| Ambrosioni, J | 1 |
| Almela, M | 2 |
| Téllez, A | 1 |
| Falces, C | 2 |
| Hernández-Meneses, M | 1 |
| Sandoval, E | 1 |
| Quintana, E | 1 |
| Vidal, B | 1 |
| Tolosana, JM | 1 |
| Fuster, D | 1 |
| Llopis, J | 1 |
| Moreno, A | 2 |
| Marco, F | 2 |
| Santos-Veloso, MAO | 1 |
| Barros, MDNDDS | 1 |
| Carvalho, MH | 1 |
| Barbosa, DACK | 1 |
| Rodrigues, JV | 1 |
| Briggs, S | 1 |
| Broom, M | 1 |
| Duffy, E | 1 |
| Everts, R | 1 |
| Everts, G | 1 |
| Lowe, B | 1 |
| McBride, S | 1 |
| Bhally, H | 1 |
| Morlanes-Gracia, P | 1 |
| Melero-Polo, J | 1 |
| Riaño-Ondiviela, A | 1 |
| Martínez-Labuena, A | 1 |
| Río-Sánchez, SC | 1 |
| Meseguer-González, D | 1 |
| Gomes, A | 1 |
| van der Wijk, L | 1 |
| Proost, JH | 1 |
| Sinha, B | 1 |
| Touw, DJ | 1 |
| Yim, J | 1 |
| Smith, JR | 1 |
| Singh, NB | 1 |
| Rice, S | 1 |
| Stamper, K | 1 |
| Garcia de la Maria, C | 2 |
| Bayer, AS | 1 |
| Mishra, NN | 1 |
| Tran, TT | 1 |
| Arias, CA | 2 |
| Sullam, P | 1 |
| Rybak, MJ | 1 |
| Khan, ZA | 1 |
| Hollenberg, SM | 1 |
| Cahill, TJ | 1 |
| Prendergast, BD | 1 |
| McGarity, GJ | 1 |
| Gil-Navarro, MV | 1 |
| Lopez-Cortes, LE | 1 |
| Luque-Marquez, R | 1 |
| Galvez-Acebal, J | 1 |
| de Alarcon-Gonzalez, A | 1 |
| Kajikawa, S | 1 |
| Oeda, T | 1 |
| Park, K | 1 |
| Yamamoto, K | 1 |
| Sugiyama, H | 1 |
| Sawada, H | 1 |
| Lavergne, A | 1 |
| Vigneau, C | 1 |
| Polard, E | 1 |
| Triquet, L | 1 |
| Rioux-Leclercq, N | 1 |
| Golbin, L | 1 |
| El Rafei, A | 1 |
| DeSimone, DC | 1 |
| Narichania, AD | 1 |
| Sohail, MR | 1 |
| Vikram, HR | 1 |
| Li, Z | 1 |
| Steckelberg, JM | 1 |
| Wilson, WR | 1 |
| Baddour, LM | 1 |
| Nagao, H | 1 |
| Yamaguchi, H | 1 |
| Ito, Y | 1 |
| Kasai, M | 1 |
| Bläckberg, A | 1 |
| Nilson, B | 2 |
| Özenci, V | 1 |
| Olaison, L | 2 |
| Rasmussen, M | 2 |
| Kanji, JN | 1 |
| Saxinger, L | 1 |
| Sleutjens, J | 1 |
| Meijer, D | 1 |
| Meregalli, PG | 1 |
| Bakker, L | 1 |
| Wagenaar, JA | 1 |
| Duim, B | 1 |
| Zomer, A | 1 |
| McCann, M | 1 |
| Gorman, M | 1 |
| McKeown, B | 1 |
| Gelfand, MS | 1 |
| Cleveland, KO | 1 |
| Fernández-Hidalgo, N | 2 |
| Almirante, B | 2 |
| Pahissa, A | 2 |
| Solla, DJ | 1 |
| Dinubile, MJ | 1 |
| Daubié, AS | 1 |
| Mayaux, J | 1 |
| Epelboin, L | 1 |
| de Tymowski, C | 1 |
| Mbadi, A | 1 |
| Jarlier, V | 1 |
| Brossier, F | 1 |
| Brownlee, WJ | 1 |
| Anderson, NE | 1 |
| Barber, PA | 1 |
| Malhotra, A | 1 |
| Rayner, J | 1 |
| Williams, TM | 1 |
| Prendergast, B | 1 |
| Angelakis, E | 2 |
| Raoult, D | 2 |
| Kwan, C | 1 |
| Chen, O | 1 |
| Radionova, S | 1 |
| Sadiq, A | 1 |
| Moskovits, M | 1 |
| Cervera, C | 1 |
| del Rio, A | 1 |
| Ninot, S | 1 |
| Armero, Y | 1 |
| Gatell, JM | 1 |
| Mestres, CA | 1 |
| Sunnerhagen, T | 1 |
| Chaparro, J | 1 |
| Murphy, E | 1 |
| Davis, C | 1 |
| Viani, RM | 1 |
| Pong, A | 1 |
| Takahashi, K | 1 |
| Uno, S | 1 |
| Sada, R | 1 |
| Buchholtz, K | 3 |
| Larsen, CT | 3 |
| Hassager, C | 3 |
| Bruun, NE | 3 |
| Mukta, V | 1 |
| Tiwari, S | 1 |
| Kalirattiname, M | 1 |
| de La Blanchardière, A | 1 |
| Fournier, PE | 1 |
| Haustraete, E | 1 |
| du Cheyron, D | 1 |
| Lepage, O | 1 |
| Verdon, R | 1 |
| Frippiat, F | 1 |
| Chandrikakumari, K | 1 |
| Moutschen, M | 1 |
| LaPlante, KL | 1 |
| Woodmansee, S | 1 |
| Izumi, K | 1 |
| Hisata, Y | 1 |
| Hazama, S | 1 |
| Thuny, F | 1 |
| Richet, H | 1 |
| Casalta, JP | 1 |
| Habib, G | 1 |
| Gupta, D | 1 |
| Green, J | 1 |
| Franco-Paredes, C | 1 |
| Lerakis, S | 1 |
| Schaadt, B | 1 |
| Béraud, G | 1 |
| Elsendoorn, A | 1 |
| Godet, C | 1 |
| Alfandari, S | 1 |
| Couet, W | 1 |
| Roblot, P | 1 |
| Roblot, F | 1 |
| Rajadhyaksha, A | 1 |
| Sonawale, A | 1 |
| Rathod, K | 1 |
| Khare, S | 1 |
| Kalal, C | 1 |
| Araoka, H | 1 |
| Kimura, M | 1 |
| Yoneyama, A | 1 |
| Gavaldà, J | 1 |
| Gurgui, M | 1 |
| Peña, C | 1 |
| de Alarcón, A | 1 |
| Ruiz, J | 1 |
| Vilacosta, I | 1 |
| Vallejo, N | 1 |
| López-Medrano, F | 1 |
| López, J | 1 |
| Hidalgo-Tenorio, C | 1 |
| Gálvez, J | 1 |
| Sáez, C | 1 |
| Lomas, JM | 1 |
| Falcone, M | 1 |
| de la Torre, J | 1 |
| Martínez-Lacasa, X | 1 |
| Munita, JM | 1 |
| Murray, BE | 1 |
| Hirata, R | 1 |
| Napoleão, F | 1 |
| Monteiro-Leal, LH | 1 |
| Andrade, AF | 1 |
| Nagao, PE | 1 |
| Formiga, LC | 1 |
| Fonseca, LS | 1 |
| Mattos-Guaraldi, AL | 1 |
| Tekin, A | 1 |
| Tekin, G | 1 |
| Turunç, T | 1 |
| Demiroğlu, Z | 1 |
| Kizilkiliç, O | 1 |
| Lin, CH | 1 |
| Hsu, RB | 1 |
| Kluge, RM | 1 |
| Lowy, FD | 1 |
| Wexler, MA | 1 |
| Steigbigel, NH | 1 |
| Siegenthaler, W | 1 |
| Fuchs, P | 1 |
| Lüthy, R | 1 |
| Mainardi, JL | 1 |
| Zhou, XY | 1 |
| Goldstein, F | 1 |
| Mohler, J | 1 |
| Farinotti, R | 1 |
| Gutmann, L | 2 |
| Carbon, C | 2 |
| Struillou, L | 1 |
| Raffi, F | 1 |
| Barrier, JH | 1 |
| Caron, F | 1 |
| Lemeland, JF | 1 |
| Humbert, G | 1 |
| Klare, I | 1 |
| Durack, DT | 1 |
| Karchmer, AW | 1 |
| Blair, R | 1 |
| Wilson, W | 1 |
| Dismukes, W | 1 |
| Tice, A | 1 |
| Gilbert, D | 1 |
| Tenenbaum, M | 1 |
| Farber, B | 1 |
| Täuber, M | 1 |
| Tseng, CY | 1 |
| Liu, PY | 1 |
| Shi, ZY | 1 |
| Lau, YJ | 1 |
| Hu, BS | 1 |
| Shyr, JM | 1 |
| Tsai, WS | 1 |
| Lin, YH | 1 |
| Wilson, AP | 1 |
| Gaya, H | 1 |
| Chow, JW | 1 |
| Davidson, A | 1 |
| Sanford, E | 1 |
| Zervos, MJ | 1 |
| Caulin, E | 1 |
| Coutrot, A | 1 |
| Collatz, E | 1 |
| Marangos, MN | 1 |
| Nicolau, DP | 1 |
| Quintiliani, R | 1 |
| Nightingale, CH | 1 |
| García Cantó, E | 1 |
| Moreno Macián, F | 1 |
| Gutiérrez Laso, A | 1 |
| Alberola Pérez, A | 1 |
| Sáez Palacios, JM | 1 |
| Izquierdo Macián, I | 1 |
| Morcillo Sopena, F | 1 |
| Meena, AK | 1 |
| Sitajayalakshmi, S | 1 |
| Prasad, VS | 1 |
| Murthy, JM | 1 |
| Zeller, NH | 1 |
| Lusk, RH | 1 |
| Palmer, DL | 1 |
| Gray, IR | 1 |
| Thomas, M | 1 |
| Heyll, A | 1 |
| Meckenstock, G | 1 |
| Vogt, M | 1 |
| Aul, C | 1 |
| Bestetti, RB | 1 |
| Figueiredo, JF | 1 |
| Da Costa, JC | 1 |
| Blin, C | 1 |
| Le Pennec, MP | 1 |
| Ghnassia, JC | 1 |
| Kassirer, JP | 1 |
| Kopelman, RI | 1 |
| Helm, E | 1 |
| Stille, W | 1 |
| Klastersky, J | 1 |
| Weerts, D | 1 |
| Hensgens, C | 1 |
| Debusscher, L | 1 |
| Schindera, F | 1 |
| Mittermayer, C | 1 |
| Pannen, F | 1 |
| Schäfer, H | 1 |
8 reviews available for gentamicin and Infective Endocarditis
| Article | Year |
|---|---|
Time to abandon ampicillin plus gentamicin in favour of ampicillin plus ceftriaxone in Enterococcus faecalis infective endocarditis? A meta-analysis of comparative trials.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Drug Therapy, Combination; Endocarditis | 2022 |
Serratia marcescens Endocarditis: A Case Report and Literature Review.
Topics: Endocarditis; Endocarditis, Bacterial; Gentamicins; Humans; Male; Positron Emission Tomography Compu | 2022 |
Valvular Heart Disease in Adults: Infective Endocarditis.
Topics: Anti-Bacterial Agents; Blood Culture; Carbapenems; Cefepime; Cephalosporins; Cross Infection; Echoca | 2017 |
Acute kidney injury during treatment with high-dose cloxacillin: a report of 23 cases and literature review.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-C | 2018 |
Infective endocarditis: therapeutic options and indications for surgery.
Topics: Anti-Infective Agents; Aortic Valve Insufficiency; Bacteremia; Cardiac Surgical Procedures; Endocard | 2014 |
Pathogenicity and treatment of Bartonella infections.
Topics: Angiomatosis, Bacillary; Anti-Bacterial Agents; Bacteremia; Bartonella; Bartonella Infections; Chlor | 2014 |
Clinical aspects of pseudomonas infections.
Topics: Agammaglobulinemia; Blood Transfusion; Burns; Carbenicillin; Cystic Fibrosis; Drug Therapy, Combinat | 1981 |
Endocarditis caused by Neisseria elongata subspecies nitroreducens: case report and literature review.
Topics: Adult; Ceftriaxone; Endocarditis; Gentamicins; Humans; Male; Neisseria | 1993 |
1 trial available for gentamicin and Infective Endocarditis
| Article | Year |
|---|---|
Once versus twice daily gentamicin dosing for infective endocarditis: a randomized clinical trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; C-Reactive Protein; Denmark; Drug Administrat | 2011 |
71 other studies available for gentamicin and Infective Endocarditis
| Article | Year |
|---|---|
Evaluation of penicillin-gentamicin and dual beta-lactam therapies in Enterococcus faecalis infective endocarditis.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Endocarditis; End | 2022 |
Topics: Abscess; Adult; Anti-Bacterial Agents; Aortic Valve; Cefotaxime; Endocarditis; Endocarditis, Bacteri | 2022 |
Impact of Enterococcus faecalis Endocarditis Treatment on Risk of Relapse.
Topics: Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Endocarditis; Endocarditis, Bacterial | 2023 |
Which trial do we need? Aminopenicillin-gentamicin versus aminopenicillin-ceftriaxone for Enterococcus faecalis endocarditis.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Drug Therapy, Combination; Endocarditis; Endocarditi | 2023 |
Diagnosis and treatment of Bartonella endocarditis.
Topics: Animals; Bartonella; Bartonella Infections; Endocarditis; Gentamicins; Humans; Zoonoses | 2019 |
Four weeks versus six weeks of ampicillin plus ceftriaxone in Enterococcus faecalis native valve endocarditis: A prospective cohort study.
Topics: Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Cohort Studies; Drug Therap | 2020 |
Cloxacillin or fosfomycin plus daptomycin combinations are more active than cloxacillin monotherapy or combined with gentamicin against MSSA in a rabbit model of experimental endocarditis.
Topics: Animals; Anti-Bacterial Agents; Cloxacillin; Daptomycin; Endocarditis; Endocarditis, Bacterial; Fosf | 2020 |
Aerococcus spp infective endocarditis following a prostate biopsy: a case report.
Topics: Aerococcus; Aged; Biopsy; Ceftriaxone; Echocardiography; Endocarditis; Female; Fever; Gentamicins; G | 2021 |
Outpatient continuous-infusion benzylpenicillin combined with either gentamicin or ceftriaxone for enterococcal endocarditis.
Topics: Anti-Bacterial Agents; Ceftriaxone; Drug Therapy, Combination; Endocarditis; Endocarditis, Bacterial | 2021 |
[La complejidad terapéutica tras el implante de una válvula aórtica transcatéter (TAVI): un caso infrecuente de trombosis y endocarditis].
Topics: Aged, 80 and over; Anti-Bacterial Agents; Aortic Valve Stenosis; Ceftriaxone; Computed Tomography An | 2021 |
Pharmacokinetic modeling of gentamicin in treatment of infective endocarditis: Model development and validation of existing models.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Endocarditis; Female; Gentamicins; Humans; Ma | 2017 |
Evaluation of daptomycin combinations with cephalosporins or gentamicin against Streptococcus mitis group strains in an in vitro model of simulated endocardial vegetations (SEVs).
Topics: Anti-Bacterial Agents; Cephalosporins; Daptomycin; Drug Therapy, Combination; Endocarditis; Gentamic | 2017 |
Reply: Infective Endocarditis, Gentamicin, and Vestibular Toxicity.
Topics: Endocarditis; Endocarditis, Bacterial; Gentamicins; Humans | 2017 |
Infective Endocarditis, Gentamicin, and Vestibular Toxicity.
Topics: Endocarditis; Endocarditis, Bacterial; Gentamicins; Humans | 2017 |
Outpatient parenteral antimicrobial therapy in Enterococcus faecalis infective endocarditis.
Topics: Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Cohort Studies; Drug Synerg | 2018 |
[A case of subarachnoid hemorrhage due to infective endocarditis by methicillin-resistant coagulase-negative staphylococcus].
Topics: Aged; Anti-Bacterial Agents; Ceftriaxone; Echocardiography, Transesophageal; Endocarditis; Gentamici | 2017 |
Comparison of Dual β-Lactam therapy to penicillin-aminoglycoside combination in treatment of Enterococcus faecalis infective endocarditis.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Drug Therapy, Combination; Electronic Health R | 2018 |
Infective Endocarditis Due to Streptococcus gallolyticus subsp. pasteurianus with Pulmonary Vein Obstruction.
Topics: Anti-Bacterial Agents; Bacteremia; Endocarditis; Endocarditis, Bacterial; Gentamicins; Humans; Infan | 2019 |
Infective endocarditis due to Streptococcus dysgalactiae: clinical presentation and microbiological features.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Outer Membrane | 2018 |
Topics: Aged, 80 and over; Animals; Anti-Bacterial Agents; Brucella; Brucellosis; Canada; Endocarditis; Gent | 2018 |
Zoonotic Endocarditis in a Man, the Netherlands.
Topics: Animals; Anti-Bacterial Agents; Endocarditis; Gentamicins; Horse Diseases; Horses; Humans; Male; Mid | 2019 |
No Fever, No Murmur, No Problem? A Concealed Case of Infective Endocarditis.
Topics: Adult; Amphetamine; Analgesics, Opioid; Anti-Bacterial Agents; C-Reactive Protein; Endocarditis; Eno | 2019 |
Combination therapy for enterococcal endocarditis.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Endocarditis; Female; Gentamicins; Gram-Positive Bac | 2013 |
Reply to Gelfand et al and Solla.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Endocarditis; Female; Gentamicins; Gram-Positive Bac | 2013 |
Effectiveness of ampicillin plus ceftriaxone compared to ampicillin plus gentamicin for treating Enterococcus faecalis infective endocarditis: a noninferiority question not yet properly investigated.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Endocarditis; Female; Gentamicins; Gram-Positive Bac | 2013 |
Rigor in the design of observational noninferiority trials.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Endocarditis; Female; Gentamicins; Gram-Positive Bac | 2013 |
False-positive pneumococcal antigen test in a case of Enterococcus faecalis meningitis.
Topics: Aged; Amoxicillin; Antibodies, Bacterial; Antigens, Bacterial; Bacterial Typing Techniques; Ceftriax | 2013 |
Intravenous thrombolysis is unsafe in stroke due to infective endocarditis.
Topics: Administration, Intravenous; Adult; Anti-Bacterial Agents; Contraindications; Echocardiography; Endo | 2014 |
Echocardiography: a case of coronary sinus endocarditis.
Topics: Adult; Anti-Bacterial Agents; Ceftazidime; Coronary Sinus; Diagnosis, Differential; Endocarditis; Fe | 2014 |
Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone.
Topics: Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Cohort Studies; Drug Resist | 2014 |
Clinical and microbiological features of infective endocarditis caused by aerococci.
Topics: Aerococcus; Aged; Aged, 80 and over; Anti-Bacterial Agents; Disk Diffusion Antimicrobial Tests; Drug | 2016 |
Chest Pain and Shortness of Breath in a Previously Healthy Teenager.
Topics: Abscess; Adolescent; Allografts; Aorta; Aortic Rupture; Aortic Valve; Aortic Valve Insufficiency; Bi | 2015 |
An 80-year-old woman surgically treated for native valve infective endocarditis caused by Citrobacter koseri.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Cefazolin; Citrobacter koseri; Endocarditis; Enterobacteri | 2017 |
Severity of gentamicin's nephrotoxic effect on patients with infective endocarditis: a prospective observational cohort study of 373 patients.
Topics: Acute Kidney Injury; Aged; Cohort Studies; Creatinine; Denmark; Endocarditis; Enterococcus; Female; | 2009 |
Bardet-Biedl syndrome with rheumatic aortic regurgitation.
Topics: Adolescent; Anesthetics, Local; Anti-Bacterial Agents; Aortic Valve Insufficiency; Aspirin; Bardet-B | 2008 |
[Infective endocarditis due to Bartonella henselae following a rupture of a cerebral aneurysm].
Topics: Adult; Angiomatosis, Bacillary; Anti-Bacterial Agents; Aortic Valve; Bartonella henselae; Endocardit | 2009 |
Gentamicin in infective endocarditis: how to use it?
Topics: Anti-Bacterial Agents; Endocarditis; Gentamicins; Humans; Kidney | 2009 |
Activities of daptomycin and vancomycin alone and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditis.
Topics: Anti-Bacterial Agents; Biofilms; Daptomycin; Endocarditis; Gentamicins; Humans; Methicillin-Resistan | 2009 |
A rare case of infective endocarditis complicated by Trichosporon asahii fungemia treated by surgery.
Topics: Anti-Bacterial Agents; Antifungal Agents; Aortic Valve; Combined Modality Therapy; Echocardiography; | 2009 |
Vancomycin treatment of infective endocarditis is linked with recently acquired obesity.
Topics: Age Factors; Aged; Anti-Bacterial Agents; Body Mass Index; Drug Therapy, Combination; Endocarditis; | 2010 |
Infective endocarditis: long-term reversibility of kidney function impairment. A 1-y post-discharge follow-up study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Creatinine; Endocarditis; Female; Follow-Up Studies; | 2010 |
Challenges in the clinical management of blood-culture negative endocarditis: case of Bartonella henselae infection.
Topics: Anti-Bacterial Agents; Antibodies, Bacterial; Aortic Valve; Bartonella henselae; Cat-Scratch Disease | 2011 |
A survey on the use of gentamicin in infective endocarditis.
Topics: Anti-Bacterial Agents; Drug Therapy; Endocarditis; France; Gentamicins; Gram-Positive Bacterial Infe | 2012 |
Mycotic aneurysm of the popliteal artery due to infective endocarditis.
Topics: Adult; Aneurysm, Infected; Angiography; Anti-Bacterial Agents; Echocardiography; Embolization, Thera | 2011 |
A surveillance of high-level gentamicin-resistant enterococcal bacteremia.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteremia; Ceftriaxone; Drug Resistance, Bacterial; Endocarditis | 2012 |
Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating enterococcus faecalis infective endocarditis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Cohort S | 2013 |
Editorial Commentary: Enterococcus faecalis infective endocarditis: is it time to abandon aminoglycosides?
Topics: Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Endocarditis; Female; Gentamicins; Gram-Positive Bac | 2013 |
Intracellular viability of toxigenic Corynebacterium diphtheriae strains in HEp-2 cells.
Topics: Anti-Bacterial Agents; Carcinoma, Squamous Cell; Corynebacterium diphtheriae; Diphtheria; Endocardit | 2002 |
Infective endocarditis and spondylodiscitis in a patient due to Aerococcus urinae: first report.
Topics: Aged; Anti-Bacterial Agents; Discitis; Drug Therapy, Combination; Endocarditis; Follow-Up Studies; G | 2007 |
Infective endocarditis caused by nutritionally variant streptococci.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Cross Infection; Endocarditis; Female; Gentam | 2007 |
Therapy of methicillin-resistant Staphylococcus epidermidis experimental endocarditis.
Topics: Animals; Anti-Bacterial Agents; Cephalothin; Disease Models, Animal; Drug Therapy, Combination; Endo | 1982 |
[Prevention of bacterial infections].
Topics: Agranulocytosis; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Endocarditis; | 1981 |
Activity of isepamicin and selection of permeability mutants to beta-lactams during aminoglycoside therapy of experimental endocarditis due to Klebsiella pneumoniae CF104 producing an aminoglycoside acetyltransferase 6' modifying enzyme and a TEM-3 beta-l
Topics: Acetyltransferases; Amikacin; Animals; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; bet | 1994 |
Triple combination penicillin-vancomycin-gentamicin for experimental endocarditis caused by a highly penicillin-and glycopeptide-resistant isolate of Enterococcus faecium.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Resistance, Microbial; Drug Synergism; | 1993 |
Home intravenous antibiotic therapy.
Topics: Anti-Bacterial Agents; Ceftriaxone; Endocarditis; Gentamicins; Home Care Services; Humans; Infusions | 1993 |
Endogenous endophthalmitis due to Escherichia coli: case report and review.
Topics: Anti-Bacterial Agents; Cefazolin; Cefotaxime; Emphysema; Endocarditis; Endophthalmitis; Escherichia | 1996 |
Treatment of endocarditis with teicoplanin: a retrospective analysis of 104 cases.
Topics: Adult; Aged; Anti-Bacterial Agents; Aortic Valve; Endocarditis; Female; Fever; Fusidic Acid; Gentami | 1996 |
Superinfection with Enterococcus faecalis during quinupristin/dalfopristin therapy.
Topics: Adult; Aged; Ampicillin; Anti-Bacterial Agents; Coronary Artery Bypass; Diabetes Mellitus, Type 1; D | 1997 |
Resistance to amikacin and isepamicin in rabbits with experimental endocarditis of an aac(6')-Ib-bearing strain of Klebsiella pneumoniae susceptible in vitro.
Topics: Acetyltransferases; Amikacin; Animals; Anti-Bacterial Agents; Colony Count, Microbial; Drug Resistan | 1996 |
Influence of gentamicin dosing interval on the efficacy of penicillin-containing regimens in experimental Enterococcus faecalis endocarditis.
Topics: Animals; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endocarditis; Enterococcus fae | 1997 |
[Effectiveness of medical treatment of endocarditis due to Candida in premature newborns].
Topics: Ampicillin; Anti-Bacterial Agents; Candida; Electrocardiography; Endocarditis; Gentamicins; Humans; | 1997 |
Mycotic aneurysm on posterior cerebral artery: resolution with medical therapy.
Topics: Adult; Anti-Bacterial Agents; Basilar Artery; Ceftriaxone; Cephalosporins; Cerebral Angiography; End | 2000 |
Nonsurgical cure of endocarditis associated with a pacemaker.
Topics: Drug Synergism; Drug Therapy, Combination; Endocarditis; Gentamicins; Humans; Male; Methicillin; Mid | 1975 |
The choice of antibiotic for treating infective endocarditis.
Topics: Adolescent; Adult; Aged; Amoxicillin; Amphotericin B; Aneurysm, Infected; Anti-Bacterial Agents; Bac | 1975 |
[Embolizing aortic valve endocarditis in the differential diagnosis of thrombotic thrombocytopenic purpura].
Topics: Anti-Bacterial Agents; Aortic Valve Insufficiency; Blood Transfusion; Diagnosis, Differential; Embol | 1992 |
Salmonella tricuspid endocarditis in an intravenous drug abuser with human immunodeficiency virus infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; Cephalosporins; Drug Therapy, Combination; Endocarditis; | 1991 |
[Serum antibacterial activity during antibiotic treatment in automated bacteriology].
Topics: Ampicillin; Anti-Bacterial Agents; Endocarditis; Escherichia coli; Gentamicins; Humans; Microbial Se | 1985 |
A man with severe valvular heart disease.
Topics: Aged; Coronary Disease; Endocarditis; Gentamicins; Heart Valve Diseases; Humans; Male; Penicillins; | 1985 |
[Clinical and therapeutic features of pseudomonas aeruginosa septicaemia].
Topics: Adult; Aged; Agranulocytosis; Bacteria; Carbenicillin; Catheterization; Colistin; Diabetes Complicat | 1972 |
Fever of unexplained origin in patients with cancer.
Topics: Bacterial Infections; Carbenicillin; Cephalothin; Endocarditis; Ethambutol; Female; Fever of Unknown | 1973 |
[Candida endocarditis of the tricuspid valve originating from an indwelling subclavian vein-SVC catheter (author's transl)].
Topics: Abdominal Injuries; Adolescent; Albumins; Ampicillin; Bicarbonates; Burns, Chemical; Candidiasis; Ca | 1974 |